Limit search to items available for checkout
Title Bad pharma : how drug companies mislead doctors and harm patients / Ben Goldacre.
Imprint New York : Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, 2013.


 Main Stacks  RM301.27 .G65 2013    AVAILABLE
Edition First American edition.
Description xvii, 426 pages : illustrations ; 22 cm.
Bibliog. Includes bibliographical references (pages 371-405) and index.
Subject Clinical Trials as Topic -- ethics.
Drug Industry -- ethics.
Drug Approval -- ethics.
Drugs -- Testing.
Drugs -- Testing -- Moral and ethical aspects.
Clinical trials -- Moral and ethical aspects.
Pharmaceutical industry -- Moral and ethical aspects.
Drugs -- Quality control.
Contents Intro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data.
Summary We like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct on a global scale affects us. This book reveals a shockingly broken system and calls for something to be done.